ABOS
Acumen Pharmaceuticals, Inc. Common Stock
stockNASDAQ
At CloseOct 30, 2026 2:27:12 PM EDT
0.23USD-90.087%(-2.06)65,141,450
Pre-marketOct 30, 2026 9:29:30 AM EDT
0.3392USD-85.188%(-1.9508)
After-hoursOct 30, 2026 4:59:30 PM EDT
0.2346USD+3.348%(+0.0076)
ABOS Financials
In Q3 FY 2026 (ended ), Acumen Pharmaceuticals, Inc. Common Stock (ABOS) reported net income of −$25.37M, operating cash flow of −$26.65M, and assets of $85.57M.
Loading financial statements…